NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Behcet's DiseaseIdiopathic Inflammatory MyopathiesIgG4-related Disease

Interventions

DRUG

Filgotinib

Trial Locations (6)

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

Zuyderland Medical Center, Heerlen

RECRUITING

Radboud university medical center, Nijmegen

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

Hagaziekenhuis, The Hague

RECRUITING

University Medical Center, Utrecht